Abstract
Introduction: Type 2 Diabetes (T2D) is a major health problem worldwide. This metabolic disease is indicated by high blood glucose levels due to insufficient insulin production by the pancreas. An inflammatory response occurs as a result of the immune response to high blood glucose levels as well as the presence of inflammatory mediators produced by adipocytes and macrophages in fat tissue. This low and chronic inflammation damages the pancreatic beta cells and leads to insufficient insulin production, which results in hyperglycemia.
Hyperglycemia in diabetes is thought to cause dysfunction of the immune response, which fails to control the spread of invading pathogens in diabetic subjects. Therefore, diabetic subjects are known to more susceptible to infections. The increased prevalence of T2D will increase the incidence of infectious diseases and related comorbidities.
Objective: This review provides an overview of the immunological aspect of T2D and the possible mechanisms that result in increased infections in diabetics.
Conclusion: A better understanding of how immune dysfunctions occur during hyperglycemia can lead to novel treatments and preventions for infectious diseases and T2D comorbidities, thus improving the outcome of infectious disease treatment in T2D patients.
Keywords: Type 2 diabetes, hyperglycemia, immune dysfunction, comorbidity, infection, treatment outcome.
Current Diabetes Reviews
Title:Type 2 Diabetes and its Impact on the Immune System
Volume: 16 Issue: 5
Author(s): Afiat Berbudi*, Nofri Rahmadika , Adi Imam Tjahjadi and Rovina Ruslami
Affiliation:
- Infectious Disease Research Center, Faculty of Medicine, Universitas Padjadjaran, Bandung,Indonesia
Keywords: Type 2 diabetes, hyperglycemia, immune dysfunction, comorbidity, infection, treatment outcome.
Abstract:
Introduction: Type 2 Diabetes (T2D) is a major health problem worldwide. This metabolic disease is indicated by high blood glucose levels due to insufficient insulin production by the pancreas. An inflammatory response occurs as a result of the immune response to high blood glucose levels as well as the presence of inflammatory mediators produced by adipocytes and macrophages in fat tissue. This low and chronic inflammation damages the pancreatic beta cells and leads to insufficient insulin production, which results in hyperglycemia.
Hyperglycemia in diabetes is thought to cause dysfunction of the immune response, which fails to control the spread of invading pathogens in diabetic subjects. Therefore, diabetic subjects are known to more susceptible to infections. The increased prevalence of T2D will increase the incidence of infectious diseases and related comorbidities.
Objective: This review provides an overview of the immunological aspect of T2D and the possible mechanisms that result in increased infections in diabetics.
Conclusion: A better understanding of how immune dysfunctions occur during hyperglycemia can lead to novel treatments and preventions for infectious diseases and T2D comorbidities, thus improving the outcome of infectious disease treatment in T2D patients.
Export Options
About this article
Cite this article as:
Berbudi Afiat *, Rahmadika Nofri , Tjahjadi Imam Adi and Ruslami Rovina , Type 2 Diabetes and its Impact on the Immune System, Current Diabetes Reviews 2020; 16 (5) . https://dx.doi.org/10.2174/1573399815666191024085838
DOI https://dx.doi.org/10.2174/1573399815666191024085838 |
Print ISSN 1573-3998 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6417 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Prostaglandin E2 Receptors as Potential Bone Anabolic Targets – Selective EP4 Receptor Agonists
Current Molecular Pharmacology Novel Human Plasma Proteins, IHRP (Acute Phase Protein) and PHBP (Serine Protease), Which Bind to Glycosaminoglycans
Current Medicinal Chemistry - Cardiovascular & Hematological Agents Accumulation of Vincristine in Calcium Chloride Elicitated Catharanthus roseus Cultures
The Natural Products Journal Effectiveness of Hsp90 Inhibitors as Anti-Cancer Drugs
Mini-Reviews in Medicinal Chemistry Current Advances and Future Challenges in Adenoviral Vector Biology and Targeting
Current Gene Therapy A Review of Traditional Japanese Medicines and their Potential Mechanism of Action
Current Pharmaceutical Design Review of Evidence that Epidemics of Type 1 Diabetes and Type 2 Diabetes/ Metabolic Syndrome are Polar Opposite Responses to Iatrogenic Inflammation
Current Diabetes Reviews Release of Growth Factors, Cytokines and Therapeutic Molecules by Hyaluronan-based Hydrogels
Current Pharmaceutical Biotechnology Phytochemical Screening, Antiproliferative and Antioxidant Properties of Various Extracts from Endemic Origanum acutidens
Combinatorial Chemistry & High Throughput Screening Cross-Talking Between PPAR and WNT Signaling and its Regulation in Mesenchymal Stem Cell Differentiation
Current Stem Cell Research & Therapy Inflammatory Fibromyalgia: Is it Real?
Current Rheumatology Reviews A Re-evaluation of the Role of Host Defence Peptides in Mammalian Immunity
Current Protein & Peptide Science Pharmacological Treatment of Obstructive Sleep Apnea
Current Pharmaceutical Design Endotoxin, Toll-like Receptor-4, and Atherosclerotic Heart Disease
Current Cardiology Reviews Lipoprotein(a) is a Therapeutic Target for Cardiovascular Disease
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) The Susceptibility of Klebsiella pneumoniae ESBL+ Strains to Clove (Syzygium aromaticum) Essential Oil
Anti-Infective Agents Application of Liposomes in Cancer Therapy: An Assessment of the Advancement of Technology Through Patent Documents
Recent Patents on Nanotechnology Pancreatic Cancer and Personalized Medicine: Can Genomics Facilitate Early Diagnosis or Improve Therapeutic Outcomes?
Current Pharmacogenomics and Personalized Medicine Mucoadhesive Low Molecular Chitosan Complexes to Protect rHuKGF from Proteolysis: <i>In-vitro</i> Characterization and FHs 74 Int Cell Proliferation Studies
Current Pharmaceutical Biotechnology PCR/SSCP Detects Reliably and Efficiently DNA Sequence Variations in Large Scale Screening Projects
Combinatorial Chemistry & High Throughput Screening